IP Library › Assignment 054057/0158
Patent Assignment
Reel/Frame 054057/0158

Assignment of Assignor's Interest

Recorded: 2020-10-14 Pages: 6
Assignor
DYNAVAX TECHNOLOGIES CORPORATION
Executed: 2020-07-31
Assignee
SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
6272 WEST 91ST AVENUE, WESTMINSTER, COLORADO, 80031
Covered Properties (4)
Combinations Including a Cpg-C Type Oligonucleotide and a Histone Deacetylase Inhibitor for Treating Cancer
Combination Including a Cpg-C Type Oligonucleotide and a Pd-1 Antagonist for Treating Breast Cancer
Combination of a Pd-1 Antagonist and Cpg-C Type Oligonucleotide for Treating Cancer
Application: 15/577,369 →
Publication: US 2018/0169229
Combination of an Anti-Il-10 Antibody and a Cpg-C Type Oligonucleotide for Treating Cancer
Application: 15/577,377 →
Publication: US 2018/0161427
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 2018
From: YU, YING; DENKER, ANDREW EVAN; SADEKOVA, SVETLANA; PHAN, UYEN TRUONG
To: MERCK SHARP & DOHME CORP.; DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 046328/0007 →
Assignment of Assignor's Interest Jun 8, 2018
From: YU, YING; CHARTASH, ELLIOT KEITH; SADEKOVA, SVETLANA; PHAN, UYEN TRUONG
To: MERCK SHARP & DOHME CORP.; DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 046027/0016 →
Assignment of Assignor's Interest Mar 26, 2020
From: SOLIMAN, HATEM
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 052239/0624 →
Assignment of Assignor's Interest Mar 26, 2020
From: JANSSEN, ROBERT S.; GAMELIN, ERICK
To: DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 052239/0638 →
Assignment of Assignor's Interest Mar 26, 2020
From: ESSERMAN, LAURA J.; CHIEN, AMY JO
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 052249/0315 →
Change of Name Oct 27, 2021
From: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
To: TRISALUS LIFE SCIENCES, INC.
Reel/Frame 057943/0686 →
Merger Jan 3, 2023
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 062264/0846 →
Security Interest Apr 30, 2024
From: TRISALUS LIFE SCIENCES, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 067274/0733 →